Format

Send to

Choose Destination
Clin Transplant. 2019 Mar 26:e13549. doi: 10.1111/ctr.13549. [Epub ahead of print]

Vancomycin-Resistant Enterococcus in Solid Organ Transplant Recipients: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.

Author information

1
Division of Infectious Diseases, Department of Medicine, University of Alabama at Birmingham.
2
Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai.

Abstract

These updated guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation address vancomycin-resistant enterococci (VRE) infections in SOT candidates and recipients. VRE are an important cause of infection and have been named by the CDC as a serious public threat. Typically, a commensal of the gastrointestinal tract, VRE may become pathogenic after abdominal organ manipulation like transplantation. This guideline reviews the microbiology, antimicrobial resistance mechanisms, epidemiology and clinical manifestations of VRE infection in the context of solid organ transplantation. Treatment regimens including combination therapies and novel investigational agents are also reviewed. Finally, an updated appraisal of infection control measures relevant to VRE infection and colonization is presented. This article is protected by copyright. All rights reserved.

KEYWORDS:

Antibiotic Resistance; Enterococcus; Transplantation

PMID:
30913322
DOI:
10.1111/ctr.13549

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center